Jane Street
BIOA

Jane Street’s BioAge Labs BIOA Stock Holding History

Jane Street’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$191K Buy
+10,900
New +$210K ﹤0.01% 10196

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Jane Street's BIOA Position: Q4 2024 in Review

Jane Street sold out of BioAge Labs (BIOA) in Q4 2024, closing a stake of 43,073 shares — an estimated $896K sold.

Jane Street first reported a position in BIOA in Q3 2024 and held it in 1 quarter. The position peaked at $896K in Q3 2024. 65 funds tracked by Wall St. Rank hold BIOA as of Q4 2024.

  • Jane Street reported no remaining BioAge Labs position as of Q4 2024 after selling out during the quarter.
  • Jane Street sold 43,073 BioAge Labs shares in Q4 2024, an estimated $896K.
  • Jane Street first reported a position in BioAge Labs in Q3 2024 and held it in 1 quarter.
  • Jane Street's BioAge Labs position peaked at $896K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held BioAge Labs as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.